Search Results - "Becker, Rüdiger"

Refine Results
  1. 1

    Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model by BIKOU, Olympia, THOMAS, Dierk, BAUER, Alexander, TRAPPE, Kerstin, LUGENBIEL, Patrick, KELEMEN, Kamilla, KOCH, Martin, SOUCEK, Radim, VOSS, Frederik, BECKER, Rudiger, KATUS, Hugo A

    Published in Cardiovascular research (01-11-2011)
    “…Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, and effective treatment of AF still remains an unmet medical need. AF is associated…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    HERG K+ channel-dependent apoptosis and cell cycle arrest in human glioblastoma cells by Staudacher, Ingo, Jehle, Julian, Staudacher, Kathrin, Pledl, Hans-Werner, Lemke, Dieter, Schweizer, Patrick A, Becker, Rüdiger, Katus, Hugo A, Thomas, Dierk

    Published in PloS one (06-02-2014)
    “…Glioblastoma (GB) is associated with poor patient survival owing to uncontrolled tumor proliferation and resistance to apoptosis. Human ether-a-go-go-related…”
    Get full text
    Journal Article
  5. 5

    Novel electrophysiological properties of dronedarone: inhibition of human cardiac two-pore-domain potassium (K2P) channels by Schmidt, Constanze, Wiedmann, Felix, Schweizer, Patrick A., Becker, Rüdiger, Katus, Hugo A., Thomas, Dierk

    “…Dronedarone is currently used for the treatment of paroxysmal and persistent atrial fibrillation (AF). Pharmacological inhibition of cardiac two-pore-domain…”
    Get full text
    Journal Article
  6. 6

    Identification and functional characterization of zebrafish K(2P)10.1 (TREK2) two-pore-domain K(+) channels by Gierten, Jakob, Hassel, David, Schweizer, Patrick A, Becker, Rüdiger, Katus, Hugo A, Thomas, Dierk

    Published in Biochimica et biophysica acta (01-01-2012)
    “…Two-pore-domain potassium (K(2P)) channels mediate K(+) background currents that stabilize the resting membrane potential and contribute to repolarization of…”
    Get more information
    Journal Article
  7. 7

    Genetic suppression of atrial fibrillation using a dominant-negative ether-a-go-go–related gene mutant by Soucek, Radim, MD, Thomas, Dierk, MD, Kelemen, Kamilla, MD, Bikou, Olympia, MD, Seyler, Claudia, PhD, Voss, Frederik, MD, Becker, Rüdiger, MD, Koenen, Michael, PhD, Katus, Hugo A., MD, Bauer, Alexander, MD

    Published in Heart rhythm (01-02-2012)
    “…Background Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. Gene therapy–dependent modulation of atrial electrophysiology may provide…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Initial experience with robotic navigation for catheter ablation of paroxysmal and persistent atrial fibrillation by Thomas, Dierk, MD, Scholz, Eberhard P., MD, Schweizer, Patrick A., MD, Katus, Hugo A., MD, Becker, Rüdiger, MD

    Published in Journal of electrocardiology (01-03-2012)
    “…Abstract Background and Purpose Remote robotic navigation (RRN) technology has been developed to facilitate catheter ablation of symptomatic atrial…”
    Get full text
    Journal Article
  10. 10

    Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation by Schweizer, Patrick A, Becker, Rüdiger, Katus, Hugo A, Thomas, Dierk

    Published in Drug design, development and therapy (06-01-2011)
    “…Atrial fibrillation (AF) is the most common sustained arrhythmia. Management of AF includes rate control, rhythm control if necessary, prevention of…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Alternative splicing determines mRNA translation initiation and function of human K2P10.1 K+ channels by Staudacher, Kathrin, Baldea, Ioana, Kisselbach, Jana, Staudacher, Ingo, Rahm, Ann‐Kathrin, Schweizer, Patrick A., Becker, Rüdiger, Katus, Hugo A., Thomas, Dierk

    Published in The Journal of physiology (01-08-2011)
    “…Non‐technical summary The resting membrane potential of excitable cells such as neurones and cardiac myocytes depends on the distribution of potassium ions…”
    Get full text
    Journal Article
  13. 13

    PKC‐dependent activation of human K2P18.1 K+ channels by Rahm, Ann‐Kathrin, Gierten, Jakob, Kisselbach, Jana, Staudacher, Ingo, Staudacher, Kathrin, Schweizer, Patrick A, Becker, Rüdiger, Katus, Hugo A, Thomas, Dierk

    Published in British journal of pharmacology (01-05-2012)
    “…BACKGROUND AND PURPOSE Two‐pore‐domain K+ channels (K2P) mediate K+ background currents that modulate the membrane potential of excitable cells. K2P18.1…”
    Get full text
    Journal Article
  14. 14

    Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3: a pre-clinical pilot study by Trappe, Kerstin, Thomas, Dierk, Bikou, Olympia, Kelemen, Kamilla, Lugenbiel, Patrick, Voss, Frederik, Becker, Rüdiger, Katus, Hugo A, Bauer, Alexander

    Published in European heart journal (01-01-2013)
    “…Atrial fibrillation (AF) is linked to cardiomyocyte apoptosis, leading to atrial remodelling and reduction in electrical conduction velocity. We hypothesized…”
    Get full text
    Journal Article
  15. 15

    Altered HCN4 channel C-linker interaction is associated with familial tachycardia-bradycardia syndrome and atrial fibrillation by Duhme, Nana, Schweizer, Patrick A, Thomas, Dierk, Becker, Rüdiger, Schröter, Julian, Barends, Thomas R M, Schlichting, Ilme, Draguhn, Andreas, Bruehl, Claus, Katus, Hugo A, Koenen, Michael

    Published in European heart journal (01-09-2013)
    “…HCN4 channels are involved in generation, regulation, and stabilization of heart rhythm and channel dysfunction is associated with inherited sinus bradycardia…”
    Get full text
    Journal Article
  16. 16

    Anxiety Disorders in Patients with Implantable Cardioverter Defibrillators: Frequency, Course, Predictors, and Patients' Requests for Treatment by LANG, SASKIA, BECKER, RÜDIGER, WILKE, STEFANIE, HARTMANN, MECHTHILD, HERZOG, WOLFGANG, LÖWE, BERND

    Published in Pacing and clinical electrophysiology (01-01-2014)
    “…Objectives To determine (1) the frequency and course of anxiety disorders in patients with implantable cardioverter defibrillators (ICDs), (2) the predictors…”
    Get full text
    Journal Article
  17. 17

    Class I antiarrhythmic drugs inhibit human cardiac two-pore-domain K+ (K2P) channels by Schmidt, Constanze, Wiedmann, Felix, Schweizer, Patrick A., Becker, Rüdiger, Katus, Hugo A., Thomas, Dierk

    Published in European journal of pharmacology (05-12-2013)
    “…Class IC antiarrhythmic drugs are commonly used for rhythm control in atrial fibrillation. In addition, class I drugs are administered to suppress ventricular…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Anti-KCNQ1 K⁺ channel autoantibodies increase IKs current and are associated with QT interval shortening in dilated cardiomyopathy by Li, Jin, Seyler, Claudia, Wiedmann, Felix, Schmidt, Constanze, Schweizer, Patrick A, Becker, Rüdiger, Katus, Hugo A, Thomas, Dierk

    Published in Cardiovascular research (01-06-2013)
    “…Autoimmune-associated proarrhythmia in dilated cardiomyopathy (DCM) is poorly understood. Given the significance of KCNQ1 potassium channels in heart rhythm…”
    Get full text
    Journal Article
  20. 20

    Implantable Defibrillators With Enhanced Detection Algorithms: Detection Performance and Safety Results from the PainFree SST Study by WOLLMANN, CHRISTIAN G., LAWO, THOMAS, KÜHLKAMP, VOLKER, BECKER, RÜDIGER, GARUTTI, CLAUDIO, JACKSON, TROY, BROWN, MARK L., MAYR, HARALD

    Published in Pacing and clinical electrophysiology (01-09-2014)
    “…Background Implantable defibrillators (ICD) are highly effective in reducing arrhythmia‐related mortality. ICD shock therapy has been shown to increase…”
    Get full text
    Journal Article